These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9577515)

  • 1. Case-control study of salmeterol and near-fatal attacks of asthma.
    Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
    Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribed drug therapy and near-fatal asthma attacks.
    Burgess C; Pearce N; Thiruchelvam R; Wilkinson R; Linaker C; Woodman K; Crane J; Beasley R
    Eur Respir J; 1994 Mar; 7(3):498-503. PubMed ID: 8013608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 5. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
    Pearce N; Grainger J; Atkinson M; Crane J; Burgess C; Culling C; Windom H; Beasley R
    Thorax; 1990 Mar; 45(3):170-5. PubMed ID: 2330548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
    Meier CR; Jick H
    Thorax; 1997 Jul; 52(7):612-7. PubMed ID: 9246132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE; Lanes SF; Kolbe J; Rea HH
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.
    Lanes SF; Lanza LL; Wentworth CE
    Am J Respir Crit Care Med; 1998 Sep; 158(3):857-61. PubMed ID: 9731017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.
    Crane J; Pearce N; Flatt A; Burgess C; Jackson R; Kwong T; Ball M; Beasley R
    Lancet; 1989 Apr; 1(8644):917-22. PubMed ID: 2565417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population.
    Castellsague J; Garcia-Rodríguez LA; Pérez-Gutthann S; Agostinis L; Cattaruzi C; Troncon MG
    Respir Med; 1999 Oct; 93(10):709-14. PubMed ID: 10581659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
    Nelson HS; Weiss ST; Bleecker ER; Yancey SW; Dorinsky PM;
    Chest; 2006 Jan; 129(1):15-26. PubMed ID: 16424409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confounding by severity does not explain the association between fenoterol and asthma death.
    Beasley R; Burgess C; Pearce N; Woodman K; Crane J
    Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.